Clinical Trial Update: Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating dorzolamide-timolol in combination with anti-VEGF injections for neovascular/wet age-related macular degeneration ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration
• Wet Macular Degeneration

Drugs mentioned

• Dorzolamide-timolol (Dorzolamide-timolol)

Snippet

Sponsor: Wills Eye | Conditions: Neovascular Age-related Macular Degeneration, Wet Macular Degeneration | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-06-19